Test - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

Featured Items

New Content

Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease

Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease

International research team identifies distinct population of neuroprotective immune cells of the central nervous system

A Specific Human Gene Can Help the Heart Repair Itself From Heart Attack or Heart Failure

A Specific Human Gene Can Help the Heart Repair Itself From Heart Attack or Heart Failure

First-ever discovery by Hina Chaudhry, MD of Mount Sinai could lead to new and less invasive treatments

Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder

Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar ...

Specialty Reports October 2025

Specialty Reports October 2025

Mount Sinai Health System is pleased to present these reports covering our groundbreaking research and compassionate, equitable, and safe patient care.

Mount Sinai Study Finds Chronic Traumatic Encephalopathy (CTE) Rare Among Individuals With Isolated Brain Injuries

Mount Sinai Study Finds Chronic Traumatic Encephalopathy (CTE) Rare Among Individuals With Isolated Brain Injuries

Chronic traumatic encephalopathy (CTE) is more common in people who experience extensive repetitive head impacts, and infrequent among individuals with isolated brain injuries or less extensive impacts, researchers from the Brain Injury ...

With the Latest Pepper Center Grant Renewal, Mount Sinai Will Build on 16 Years of Pioneering Work in Geriatrics and Palliative Medicine

With the Latest Pepper Center Grant Renewal, Mount Sinai Will Build on 16 Years of Pioneering Work in Geriatrics and Palliative Medicine

The latest renewal of the Brookdale Department of Geriatrics and Palliative Medicine’s Pepper Center grant in August 2025 by the National Institute on Aging presents an opportunity to focus on new initiatives to improve the quality of ...

Brookdale Staff Voices Its Concerns Post-Pandemic, and Community Building Teams Respond

Brookdale Staff Voices Its Concerns Post-Pandemic, and Community Building Teams Respond

Consensus Defines Postpartum Psychosis as Distinct Clinical Entity

Consensus Defines Postpartum Psychosis as Distinct Clinical Entity

An international panel of leading experts on women’s mental health is recommending that postpartum psychosis be recognized as a distinct category of mental illness and classified accordingly within standardized medical coding systems.

Mount Sinai’s MASLD/MASH Center of Excellence Focuses on Liver Disease Science and Treatment

Mount Sinai’s MASLD/MASH Center of Excellence Focuses on Liver Disease Science and Treatment

Raising public awareness of MASH (metabolic dysfunction-associated steatohepatitis) and its precursor condition, MASLD (metabolic dysfunction-associated steatotic liver disease), is a top priority for Mount Sinai's MASLD/MASH Center of ...

ARPA-H Funds Mount Sinai Research to Inhibit Cellular Mechanisms of Viral Spread

ARPA-H Funds Mount Sinai Research to Inhibit Cellular Mechanisms of Viral Spread

Researchers at the Icahn School of Medicine at Mount Sinai have received up to $11.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to identify and block the cellular entry points viruses exploit to infect, replicate, and spread.

Improving MASH Treatment With Medically Tailored Meals

Improving MASH Treatment With Medically Tailored Meals

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators are launching an innovative new program to deliver medically tailored meals to people with steatotic liver disease. The goal is to make behavioral lifestyle changes more achievable.

Living Brain Project: Obtaining Prefrontal Cortex Biopsies During Deep Brain Stimulation Adds No Risk to Procedure

Living Brain Project: Obtaining Prefrontal Cortex Biopsies During Deep Brain Stimulation Adds No Risk to Procedure

Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that do not involve biopsies, a team ...

Breakthrough Study Could Transform Treatment for Patients With Severe Limb Injuries

Breakthrough Study Could Transform Treatment for Patients With Severe Limb Injuries

In the study, published on the front page of Clinical Orthopaedics and Related Research in June 2025, Mount Sinai Health System’s Michael R. Hausman, MD; Paul J. Cagle Jr., MD; and Christoph A. Schroen, a doctoral student, identify a new ...

Providing Comprehensive Care for Patients With Microtia and Atresia

Providing Comprehensive Care for Patients With Microtia and Atresia

Patients with microtia and atresia, along with their families, often face difficult decisions as they navigate hearing loss and social stigma. At the Ear Institute at New York Eye and Ear Infirmary of Mount Sinai, they receive personalized ...

Mount Sinai Studies Reveal Molecular Gaps in Living vs. Postmortem Brain

Mount Sinai Studies Reveal Molecular Gaps in Living vs. Postmortem Brain

Two new research papers from the landmark Living Brain Project at Mount Sinai present what is, by several metrics, the largest investigation ever performed of the biology of the living human brain

Augmenting Neurostimulation Treatments With Motion Capture Technology

Augmenting Neurostimulation Treatments With Motion Capture Technology

The Charles Lazarus Children’s Abilities Center at Mount Sinai is one of only two institutions in New York City that will have a marker-based, multi-camera motion capture facility. This facility will enable the Center to be the first nationwide ...

A Novel Gene Therapy to Treat Phelan-McDermid Syndrome-Associated Autism

A Novel Gene Therapy to Treat Phelan-McDermid Syndrome-Associated Autism

Autism spectrum disorders are increasingly understood to have a genetic component, but with the number of genes that could be involved in the disorder, developing a treatment is challenging. However, for autism associated with Phelan-McDermid ...

Mount Sinai Outcomes Support Ross Procedure in Younger Patients

Mount Sinai Outcomes Support Ross Procedure in Younger Patients

Long-term outcomes from Mount Sinai’s extensive experience with the Ross procedure demonstrate its safety, durability, and effectiveness as a preferred surgical option for younger patients with aortic valve disease.